Retinoic acid signaling controls urothelial development and regeneration

视黄酸信号控制尿路上皮的发育和再生

基本信息

项目摘要

DESCRIPTION (provided by applicant): The urothelium is a stratified epithelium composed of Krt5-expressing basal cells, intermediate cells, and a luminal layer of umbrella cells that provide a crucial barrier between the urinary tract and blood. The urothelium contains stem cells that can regenerate the umbrella cell layer after acute damage, but chronic damage can compromise the urothelial barrier, leading to bladder dysfunction and persistent pain. Identification of urothelial stem cells and the signaling pathways that control them will be important for developing strategies for bladder augmentation and repair. Fate mapping studies reveal the existence of a Sonic hedgehog (Shh) expressing stem cell population in the adult urothelium that is proposed to be a basal cell. Our studies indicate that an Shh+ cell is also a stem cell in the embryonic urothelium, however direct analysis of the stem cell potential of basal cells using Krt5CreERT2;Rosa26 mice in fate mapping experiments reveals that they are unipotent in the adult and embryonic urothelium, suggesting that a different urothelial cell type i the stem cell. Consistent with this, we find that two other cell types are present in the Shh+ population, intermediate cells, and U-0 cells, a population that has not been previously described. We will test the stem cell potential intermediate and U-0 cells in Aims 1 and 2 in in the embryonic and adult regenerating urothelium, using CPP and uropathogenic E. coli as injury models, in collaboration with Indira Mysorekar's lab. Retinoic acid (RA) is a potent signaling molecule that can induce embryonic stem cells to differentiate into urothelial cells in culture, suggesting that retinoids may normally regulate urothelial progenitors. To address this, we used the ShhCre line to express a dominant inhibitory RA-receptor (RaraDN) which has been inserted into the Rosa26 locus, in the Shh+ population. We find that neither intermediate cells nor umbrella cells form in ShhCre/+;RaraDN mutants suggesting that retinoids are normally important in progenitor population for urothelial specification. We will directly address this question using cell type specific Cre lines to express RaraDN in intermediate and U-0 cells to determine which urothelial populations are mediators of RA-signaling during development and in the adult urothelium. These studies will identify a novel urothelial stem cell population, and will define the role of RA-signaling in formation and regeneration of the urothelium. The potential for RA to by used for induction of epithelial subtypes in the urothelium raises the possibility that a readily available and inexpensive compound could have novel therapeutic applications.
描述(申请人提供):尿路上皮是一种复层上皮,由表达Krt5的基底细胞、中间细胞和一层伞状细胞组成。 尿路和血液之间的重要屏障。尿路上皮含有干细胞,可以在急性损伤后再生伞状细胞层,但慢性损伤会损害尿路上皮屏障,导致膀胱功能障碍和持续性疼痛。鉴定尿路上皮干细胞和控制它们的信号通路对于开发膀胱增强和修复策略将是重要的。命运图谱研究表明,在成人尿路上皮中存在一个表达干细胞群的Sonic Hedgehog(Shh),该干细胞被认为是一种基底细胞。我们的研究表明Shh+细胞也是胚胎尿路上皮中的干细胞,然而使用Krt5CreERT2;rosa26小鼠在命运映射实验中直接分析基本细胞的干细胞潜力显示它们在成年和胚胎尿路上皮中是单能的,这表明不同类型的尿路上皮细胞I是干细胞。与此一致,我们发现Shh+细胞群中存在另外两种细胞类型,中间细胞和U-0细胞,这是以前没有描述过的群体。我们将与Indira Mysorekar的实验室合作,以CPP和致尿性大肠杆菌为损伤模型,在胚胎和成人再生尿路上皮细胞中测试AIMS 1和2中的干细胞潜在中间体和U-0细胞。 维甲酸(RA)是一种有效的信号分子,可以诱导胚胎干细胞在培养中分化为尿路上皮细胞,提示维甲酸类物质可能对尿路上皮祖细胞有正常的调节作用。为了解决这个问题,我们使用ShhCre系来表达一个显性的抑制性RA受体(RaraDN),它已经插入到Shh+人群的rosa26基因座中。我们发现在ShhCre/+;RaraDN突变体中既没有中间细胞也没有伞状细胞形成,这表明维甲酸在尿路上皮规范的前体细胞群中通常是重要的。我们将直接使用细胞类型特定的Cre系来表达这个问题 在中间细胞和U-0细胞中的RaraDN,以确定哪些尿路上皮群体是发育期间和成人尿路上皮中RA信号的介体。这些研究将确定一个新的尿路上皮干细胞群体,并将确定RA信号在尿路上皮形成和再生中的作用。RA被用来诱导尿路上皮细胞亚型的可能性增加了一种容易获得和廉价的化合物可能具有新的治疗应用的可能性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CATHY Lee MENDELSOHN其他文献

CATHY Lee MENDELSOHN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CATHY Lee MENDELSOHN', 18)}}的其他基金

GENERATING AN ATLAS OF THE DEVELOPING HUMAN URINARY OUTFLOW TRACT.
生成人类尿路流出道发育图谱。
  • 批准号:
    9351174
  • 财政年份:
    2016
  • 资助金额:
    $ 24万
  • 项目类别:
Transcriptional regulation of urothelial differentiation and cell type specification during homeostasis and regeneration
稳态和再生过程中尿路上皮分化和细胞类型规范的转录调控
  • 批准号:
    10487498
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Transcriptional Regulation of Urothelial Differentiation During Homeostasis and Repair in Response to Urinary Tract Infection
尿路感染的稳态和修复过程中尿路上皮分化的转录调控
  • 批准号:
    10022310
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10700947
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Transcriptional regulation of urothelial differentiation and cell type specification during homeostasis and regeneration
稳态和再生过程中尿路上皮分化和细胞类型规范的转录调控
  • 批准号:
    10297546
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10022307
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10487484
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10297543
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Transcriptional regulation of urothelial differentiation and cell type specification during homeostasis and regeneration
稳态和再生过程中尿路上皮分化和细胞类型规范的转录调控
  • 批准号:
    10700956
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
Retinoic acid signaling controls urothelial development and regeneration
视黄酸信号控制尿路上皮的发育和再生
  • 批准号:
    9086366
  • 财政年份:
    2013
  • 资助金额:
    $ 24万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了